• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2100081 IBI321 IBI-321 Injection Biological Products(1) New Drug Application 2021-03-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-03-03 view
CYSB2100055 利妥昔单抗注射液 rituximab Injection Biological Products Supplementary Application 2021-02-06 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2022-01-27 view
CXHL2100072 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXHL2100071 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXHL2100073 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXSL2100029 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2021-01-23 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-22 view
CXSS2100008 贝伐珠单抗注射液 bevacizumab Injection Biological Products(2.2) New Drug Application 2021-01-13 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-12 view
CXSS2100007 信迪利单抗注射液 sintilimab Injection Biological Products(2.2) New Drug Application 2021-01-13 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2021-11-05 view
CXSS2100009 信迪利单抗注射液 sintilimab Injection Biological Products(2.2) New Drug Application 2021-01-13 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-12 view
CXSB2100002 信迪利单抗注射液 sintilimab Injection Biological Products(原1) Supplementary Application 2021-01-06 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2021-09-02 view
CYSB2100001 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-01-06 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2022-01-27 view
JXHL2000323 Parsaclisib片 parsaclisib Tablet Chemical Drugs(1) Import Drug Application 2020-12-14 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-12-10 view
JXHL2000322 Parsaclisib片 parsaclisib Tablet Chemical Drugs(1) Import Drug Application 2020-12-14 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-12-10 view
CXSL2000304 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2020-10-28 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-10-27 view
CYSB2000230 贝伐珠单抗注射液 bevacizumab Injection Biological Products Supplementary Application 2020-10-20 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-12-28 view
CYSB2000225 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2020-10-13 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-12-28 view
CYSB2000220 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2020-09-30 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-11-26 view
CYSB2000219 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2020-09-30 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-12-28 view
CXSL2000274 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2020-09-28 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-09-28 view
CXSL2000263 IBI188 letaplimab Injection Biological Products(1) New Drug Application 2020-09-12 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-09-11 view